Skip to main content
OpenTrials
Completed

NCT Number: NCT07233460

Effect of Using Bitter Melon, Blueberries and Cranberries on HbA1c and Diabetes Symptom Levels

This double-blind, randomized controlled trial investigated the effect of bitter melon, blueberry, and cranberry powder extract use on glycemic control and diabetes symptom levels in individuals with T2DM.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gümüşhane University

Gümüşhane, 29600, Turkey (Türkiye)

About this study

The increasing prevalence of Type 2 Diabetes Mellitus (T2DM) worldwide and the search for additional support to current treatments have increased interest in researching natural components such as bitter melon, blueberry, and cranberry, known for their antioxidant and hypoglycemic potential, as complementary therapies. This double-blind, randomized controlled trial investigated the effect of bitter melon, blueberry, and cranberry powder extract use on glycemic control and diabetes symptom levels in individuals with T2DM.

The study, conducted with four groups (bitter melon, blueberry, cranberry, and control), included 120 individuals diagnosed with T2DM. Individuals in the experimental group used 10g of powdered extract daily for 12 weeks, while those in the control group used nothing. The 'Patient Information Form' and 'Diabetes Symptoms Checklist Scale' were administered before the start of the study (pre-test/week 0) and at the end (post-test/week 12), and the venous blood value of the Hemoglobin A1c test (HbA1c) was measured.

In the experimental groups (bitter melon, blueberry, cranberry), after 12 weeks of treatment, statistically significant decreases were observed in HbA1c, the total score and all Subdimensions scores of the 'Diabetes Symptoms Checklist Scale', weight, and BMI compared to the control group; while in the control group, there was a significant increase in all parameters except HbA1c (p<0.05). Although there was no difference between the experimental (bitter melon, blueberry, cranberry) groups in the intergroup measurements, HbA1c, the total mean scores of the Diabetes Symptom Checklist Scale, weight, and BMI were found to be significantly lower than in the control group (p<0.05).

Bitter melon, blueberry, and cranberry powder extracts were found to be equally effective in reducing HbA1c, diabetes symptoms, weight, and BMI in T2DM patients. The lack of difference in efficacy between the three extracts in terms of glycemic and symptom levels suggests that these three natural products can be considered equivalent therapeutic options in the complementary treatment of T2DM.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being 18 years of age or older,
  • Volunteering to participate in the study,
  • Being conscious and able to communicate,
  • Having been diagnosed with T2DM at least 3 months prior and currently using oral antidiabetic medication,
  • Be using one of the following powder extracts-bitter melon, blueberry, or cranberry-for the first time as a complementary treatment upon a physician's recommendation and be on the first day of use,
  • Not taking any other medications that affect blood sugar,
  • No allergy to bitter melon, blueberry, or cranberry,
  • Not engaging in exercise,
  • Taking 10g of bitter melon, blueberry, or cranberry powder extract daily.

Exclusion criteria

  • Not meeting the inclusion criteria, having a known psychological disorder,
  • Having previously received complementary therapy for DM, or having hearing loss.

Treatment and study plan

Bitter Melon Group

Other

Patients who voluntarily used bitter melon powder extract continued to consume 1 teaspoon (10 g total) of powdered extract mixed with yogurt or water twice a day (morning and evening) for 12 weeks.

Blueberry Group

Other

Patients who voluntarily used bitter blueberry powder extract continued to consume 1 teaspoon (10 g total) of powdered extract mixed with yogurt or water twice a day (morning and evening) for 12 weeks.

Cranberry Group

Other

Patients who voluntarily used cranberry powder extract continued to consume 1 teaspoon (10 g total) of powdered extract mixed with yogurt or water twice a day (morning and evening) for 12 weeks.

Primary outcomes

  1. HbA1c

    Time frame: 12 week

    Unlike instant blood glucose values, HbA1c reliably reflects an individual's average blood sugar level over the past two to three months by measuring the amount of glucose bound to hemoglobin during the average lifespan of erythrocytes (approximately 120 days).

    Before starting the study (pre-test/week 0) HbA1c venous blood values were measured. Patients who voluntarily used bitter melon, blueberry, or cranberry continued to consume 1 teaspoon (10 g total) of powdered extract mixed with yogurt or water twice a day (morning and evening) for 12 weeks. At the end of the study (post-test/12th week), the was administered again to individuals HbA1c venous blood values were measured.

  2. Diabetes Symptom Checklist Scale

    Time frame: 12 week

    The scale consists of a total of 34 items. These categories are: neurology (3, 11, 15, 21, 25, 34), psychology (1, 2, 4, 6, 17, 20), cardiology (5, 8, 9, 13, 24, 26, 29, 30), ophthalmology (10, 14, 22, 28), psychology/cognition (7, 19, 27, 31, 33), and hyperglycemia (12, 16, 23, 32) Subdimensionss. Responses on the scale are numbered from 0 to 5, with "0" meaning "none" and "5" meaning "extremely."

    Before starting the study (pre-test/week 0), all group participants first completed "Diabetes Symptom Checklist Scale" were measured. Patients who voluntarily used bitter melon, blueberry, or cranberry continued to consume 1 teaspoon (10 g total) of powdered extract mixed with yogurt or water twice a day (morning and evening) for 12 weeks. At the end of the study (post-test/12th week), the "Diabetes Symptom Checklist Scale" was administered again to individuals were measured.

Sponsors and collaborators

Lead sponsor

Hatice Demirağ, Ph.D

Other

Collaborators

  • Karadeniz Technical University

Registry information

Official study title

Effect of Use of Bitter Melon, Blueberry and Cranberry as Complementary Therapy on HbA1c and Diabetes Symptom Level in Individuals With Type 2 Diabetes Mellitus: Single-blind Randomized Controlled Study

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Nov 18, 2025
Registry last updated
Nov 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.